Advisory Council for the Elimination of Tuberculosis (ACET), 65592-65593 [2022-23641]
Download as PDF
<![CDATA[
65592
Federal Register / Vol. 87, No. 209 / Monday, October 31, 2022 / Notices
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH or the Advisory
Board). This is a hybrid meeting,
accessible both in person and virtually.
It is open to the public, limited only by
the space available and the number of
audio conference lines and internet
conference accesses. Time will be
available for public comment. The
public is also welcome to submit
written comments in advance of the
meeting, to the contact person listed in
the addresses section below.
DATES: The meeting will be held on
December 8, 2022, from 9:00 a.m. to
6:00 p.m., EST. A public comment
session will be held on December 8,
2022, at 5:00 p.m., EST, and will
conclude at 6:00 p.m., EST, or following
the final call for public comment,
whichever comes first.
Written comments must be received
on or before December 1, 2022.
ADDRESSES: St. Petersburg Marriott
Clearwater, 12600 Roosevelt Boulevard,
North, St. Petersburg, Florida 33716;
Telephone: (727) 572–7800. The
conference room will have seating for
approximately 120 people.
The USA toll-free dial-in numbers are:
+1–669–254–5252 US (San Jose); and
+1–646–828–7666 US (New York). The
meeting ID is: 161 949 4327; the
Passcode is: 46823450; and the Web
conference by Zoom meeting connection
is: https://cdc.zoomgov.com/j/16194
94327?pwd=MWlycXpYUzdmTElpb
Upld1pRNlM4QT09. The combined
number of audio conference lines and
internet conference accesses is 200.
You may submit comments by mail
to: Dr. Rashaun Roberts, National
Institute for Occupational Safety and
Health (NIOSH), CDC, 1090 Tusculum
Avenue, Mailstop C–24, Cincinnati,
Ohio 45226. Written comments received
in advance of the meeting will be
included in the official record of the
meeting.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:15 Oct 28, 2022
Jkt 259001
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226; Telephone:
(513) 533–6800; Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines,
which have been promulgated by HHS
as a final rule; advice on methods of
dose reconstruction, which have also
been promulgated by HHS as a final
rule; advice on the scientific validity
and quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC). In December
2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, was renewed
at appropriate intervals, was rechartered
under Executive Order 13889 on March
22, 2022, and will terminate on March
22, 2024.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Considered: The agenda
will include discussions on the
following: NIOSH Program Update;
Department of Labor Program Update;
Department of Energy Program Update;
SEC Petitions Update; Procedures
Review Finalization/Document
Approvals; Rocky Flats Plant Work
Group Update; Update on Review of
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
SEC–00256 Pinellas Plant Evaluation
Report; and a Board Work Session.
Agenda items are subject to change as
priorities dictate.
For additional information, please
contact Toll Free 1–800–232–4636.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–23645 Filed 10–28–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis (ACET)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Council for the
Elimination of Tuberculosis (ACET).
This meeting is open to the public and
limited to 1,000 audio and web
conference lines. Members of the public
are welcome to listen to the meeting by
accessing the telephone number and
web access provided in the addresses
section below. Time will be available for
public comment (registration required to
provide oral comment).
DATES: The meeting will be held on
December 13, 2022, from 10:00 a.m. to
5:00 p.m., EST, and December 14, 2022,
from 10:00 a.m. to 12:00 p.m., EST.
Written comments must be submitted by
November 29, 2022. Registration to
make oral comments must also be
submitted by November 29, 2022.
ADDRESSES: The telephone access
number is 1–669–254–5252, Webinar
ID: 161 095 9944, and the Passcode is
42236876. The web conference access is
https://cdc.zoomgov.com/j/1610959944?
pwd=eGhxZFNaeFJscGo2e
TVwZ0ZOZ3d4QT09, and the Passcode
SUMMARY:
E:\FR\FM\31OCN1.SGM
31OCN1
Federal Register / Vol. 87, No. 209 / Monday, October 31, 2022 / Notices
is E=7@trcA. The number of available
audio and web conference lines is 1,000.
Prevention and the Agency for Toxic
Substances and Disease Registry.
FOR FURTHER INFORMATION CONTACT:
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Marah Condit, MS, Committee
Management Lead, National Center for
HIV, Viral Hepatitis, STD, and TB
Prevention, CDC, 1600 Clifton Road NE,
Mailstop US8–6, Atlanta, Georgia
30329–4027; Telephone: (404) 639–
3423; Email: nchhstppolicy@cdc.gov.
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Purpose: The Council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis (TB).
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters To Be Considered: The agenda
will include discussions on (1)
electronic data systems for overseas
medical evaluations; (2) TB commercial
diagnostics; (3) TB screening in the
Uniting for Ukraine response; (4) CDC
electronic directly observed therapy
recommendations; and (5) the TB
Elimination Alliance. Agenda items are
subject to change as priorities dictate.
[FR Doc. 2022–23641 Filed 10–28–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1790–N]
Medicare Program; Public Meeting for
New Revisions to the Healthcare
Common Procedure Coding System
(HCPCS) Coding—November 29–
December 1, 2022
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
dates and times of the virtual Healthcare
Common Procedure Coding System
(HCPCS) public meetings to be held
November 29, 2022 through December
1, 2022 to discuss our preliminary
coding, Medicare benefit category, and
payment determinations for new
revisions to the HCPCS Level II code set,
as well as how to register for those
meetings.
SUMMARY:
Public Participation
DATES:
Written Public Comment: Members of
the public are welcome to submit
written comments in advance of the
meeting. Written comments must be
submitted by emailing nchhstppolicy@
cdc.gov with subject line ‘‘December
2022 ACET Public Comment
Registration’’ by November 29, 2022.
Oral Public Comment: Individuals
who would like to make an oral
comment during the public comment
period must register by emailing
nchhstppolicy@cdc.gov with subject
line ‘‘December 2022 ACET Public
Comment Registration’’ by November
29, 2022. The public comment period is
on December 13, 2022, at 4:45 p.m.,
EST.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Virtual Meeting Dates: Tuesday,
November 29, 2022, 9 a.m. to 5 p.m.,
eastern standard time (e.s.t.),
Wednesday, November 30, 2022, 9 a.m.
to 5 p.m. e.s.t., and Thursday, December
1, 2022, 9 a.m. to 5 p.m. e.s.t.
Deadline for Primary Speaker
Registrations and Presentation
Materials: The deadline for primary
speakers to register and submit any
supporting PowerPoint presentation, as
well as any relevant studies published
after the date the applicant submitted its
HCPCS code application, is 5 p.m.,
e.s.t., Tuesday, November 15, 2022.
Deadline for 5-Minute Speaker
Registrations: The deadline for
registering to be a 5-minute speaker is
5 p.m., e.s.t., Tuesday, November 15,
2022.
Deadline for Registration for all Other
Attendees: All individuals who plan to
attend the virtual public meetings to
listen, but do not plan to speak, must
register to attend. Attendees can attend
more than one meeting. Except for
individuals who require special
assistance, the deadline to register for
each public meeting is the date of that
VerDate Sep<11>2014
17:15 Oct 28, 2022
Jkt 259001
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
65593
public meeting. Individuals who plan to
attend one or more of the virtual public
meetings and require special assistance
must register and request special
assistance services by Tuesday,
November 15, 2022.
Registration Link: The registration
link will be posted in the Guidelines for
Participation in HCPCS Public Meetings
document on the CMS website at
https://www.cms.gov/Medicare/Coding/
MedHCPCSGenInfo/HCPCSPublic
Meetings and in an announcement on
the HCPCS General Information page at
https://www.cms.gov/Medicare/Coding/
MedHCPCSGenInfo. The same website
also contains detailed information on
how attendees can join the virtual
public meetings using Zoom, including
dial-in information for primary
speakers, 5-minute speakers, and all
other attendees.
Deadline for Submission of Written
Comments: In addition to the primary
speaker presentation materials noted
above, CMS will accept written
comments from any stakeholder
pertaining to a HCPCS code application
or agenda item scheduled for discussion
at the public meetings. The deadline for
submission of written comments
pertaining to a specific HCPCS code
application or agenda item is 5 p.m.,
e.s.t., on the date of the virtual public
meeting at which the applicable HCPCS
code application or agenda item is
scheduled for discussion. Written
comments will only be accepted when
emailed to: HCPCS@cms.hhs.gov.
ADDRESSES: Virtual Meeting Location:
The November 29, 2022 through
December 1, 2022 HCPCS public
meetings will be held virtually via
Zoom only.
FOR FURTHER INFORMATION CONTACT:
Sundus Ashar, (410) 786 0750,
Sundus.ashar1@cms.hhs.gov, or
HCPCS@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
On December 21, 2000, Congress
enacted the Medicare, Medicaid, and
State Children’s Health Insurance
Program (SCHIP) Benefits Improvement
and Protection Act of 2000 (BIPA) (Pub.
L. 106–554). Section 531(b) of BIPA
mandated that the Secretary establish
procedures that permit public
consultation for coding and payment
determinations for new durable medical
equipment (DME) under Medicare Part
B of title XVIII of the Social Security Act
(the Act). In the November 23, 2001
Federal Register (66 FR 58743), we
published a notice providing
information regarding the establishment
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 87, Number 209 (Monday, October 31, 2022)]
[Notices]
[Pages 65592-65593]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23641]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis (ACET)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Advisory Council for the
Elimination of Tuberculosis (ACET). This meeting is open to the public
and limited to 1,000 audio and web conference lines. Members of the
public are welcome to listen to the meeting by accessing the telephone
number and web access provided in the addresses section below. Time
will be available for public comment (registration required to provide
oral comment).
DATES: The meeting will be held on December 13, 2022, from 10:00 a.m.
to 5:00 p.m., EST, and December 14, 2022, from 10:00 a.m. to 12:00
p.m., EST. Written comments must be submitted by November 29, 2022.
Registration to make oral comments must also be submitted by November
29, 2022.
ADDRESSES: The telephone access number is 1-669-254-5252, Webinar ID:
161 095 9944, and the Passcode is 42236876. The web conference access
is https://cdc.zoomgov.com/j/1610959944?pwd=eGhxZFNaeFJscGo2eTVwZ0ZOZ3d4QT09, and the Passcode
[[Page 65593]]
is [email protected] The number of available audio and web conference lines is
1,000.
FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management
Lead, National Center for HIV, Viral Hepatitis, STD, and TB Prevention,
CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, Georgia 30329-4027;
Telephone: (404) 639-3423; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis (TB). Specifically, the Council makes recommendations
regarding policies, strategies, objectives, and priorities; addresses
the development and application of new technologies; and reviews the
extent to which progress has been made toward eliminating tuberculosis.
Matters To Be Considered: The agenda will include discussions on
(1) electronic data systems for overseas medical evaluations; (2) TB
commercial diagnostics; (3) TB screening in the Uniting for Ukraine
response; (4) CDC electronic directly observed therapy recommendations;
and (5) the TB Elimination Alliance. Agenda items are subject to change
as priorities dictate.
Public Participation
Written Public Comment: Members of the public are welcome to submit
written comments in advance of the meeting. Written comments must be
submitted by emailing [email protected] with subject line
``December 2022 ACET Public Comment Registration'' by November 29,
2022.
Oral Public Comment: Individuals who would like to make an oral
comment during the public comment period must register by emailing
[email protected] with subject line ``December 2022 ACET Public
Comment Registration'' by November 29, 2022. The public comment period
is on December 13, 2022, at 4:45 p.m., EST.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-23641 Filed 10-28-22; 8:45 am]
BILLING CODE 4163-18-P
